Title

Correction: 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis.

Document Type

Article

Publication Date

3-26-2018

Keywords

anti-tnf; dmards (biologic); psoriatic arthritis; tnf-alpha

Abstract

[This corrects the article DOI: 10.1136/rmdopen-2017-000582.][This corrects the article DOI: 10.1136/rmdopen-2017-000582.].

Clinical Institute

Orthopedics & Sports Medicine

Department

Orthopedics

Department

Rheumatology

Volume

4

Issue

1

PubMed ID

29595841

Journal Title

RMD Open

Share

COinS